Harvest Health & Recreation Inc. Announces Divestiture of North Dakota Assets

Harvest Health & Recreation Inc. (“Harvest”) (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., has completed the divestiture of its dispensary assets in North Dakota. A local operator acquired Harvest’s two medical marijuana dispensaries located in Bismarck and Williston, North Dakota.

Cresco Labs Closes Acquisition of Verdant Creations’ Four Dispensaries

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated, multistate cannabis operators in the United States, announced today the closing of its acquisition of Verdant Creations dispensaries in Cincinnati, Chillicothe, Newark and Marion, Ohio (collectively “Verdant”). These acquisitions give Cresco four additional dispensaries, bringing the Company’s dispensary presence in Ohio to five – the maximum allowed by the state.

Columbia Care Signs Definitive Agreement to Acquire Green Leaf Medical

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) has signed a definitive agreement to acquire Green Leaf Medical, LLC (“Green Leaf”), a privately held, fully-integrated cannabis multi-state operator (MSO) based in the mid-Atlantic region, for approximately $240 million with the potential for additional performance-based milestone payments. Following the close of two acquisitions that established Columbia Care as a market leader in the two largest cannabis markets in the world, California and Colorado, the acquisition of Green Leaf expands Columbia Care’s operational scale and footprint in four key, limited license markets by materially enhancing the scale and capabilities of its seed-to-sale operations.

Rapid Therapeutic Completes $14M Acquisition of Razor Jacket

Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on employing FDA-approved Metered Dose Inhaler (MDI) technology to deliver cannabinoid compounds, such as CBD, CBG, and CBN, announced today that it has closed on a transaction acquiring all of the assets of Razor Jacket, LLC based in Hillsboro, Oregon. The transaction is valued at $14 million in cash and stock which includes all potential future earnouts of $13.2 Million.

TerrAscend Expands U.S. Footprint via Acquisition of Maryland Based Grower Processor

TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE:TER,) (OTCQX: TRSSF), a leading North American cannabis operator, announced the signing of a definitive agreement to acquire HMS Health, LLC and HMS Processing, LLC (collectively “HMS”) from Curaleaf Holdings, Inc (“Curaleaf”) (CSE: CURA) (OTCQX: CURLF). HMS is a cultivator and processor of medical cannabis products in the state of Maryland. The acquisition is expected to be immediately accretive to TerrAscend on an EBITDA basis. “This acquisition enables TerrAscend to expand its footprint into another robust limited license medical cannabis market with strong, long-term growth potential,” said Jason Ackerman, Executive Chairman and Chief Executive Officer of TerrAscend.

SOL Global Investments Core Portfolio Company Verano Holdings Announces Acquisition and Combination

SOL Global Investments Corp. (“SOL Global” or the “Company”) (CSE: SOL) (OTCPK: SOLCF) (Frankfurt: 9SB) is pleased to announce that Verano Holdings, LLC (“Verano”), the Company’s largest core investment holding, announced today the signing of a definitive merger agreement to acquire and combine operations with Alternative Medical Enterprises, LLC, Plants of Ruskin, LLC, and affiliated companies (collectively, “AltMed”), vertically-integrated medical cannabis companies that apply pharmaceutical industry standards to developing, cultivating, producing, and dispensing medical cannabis and medical cannabis products in Florida and Arizona.

Helix Technologies, Inc. and Medical Outcomes Research Analytics, LLC to Combine

Helix Technologies, Inc. (OTCQB:HLIX) and Medical Outcomes Research Analytics, LLC (MOR Analytics) announced Saturday they have entered into an agreement to combine, creating an innovative healthcare information, analytics and technology organization. Helix’s industry-leading compliance and point of sale technologies are tailored to the unique needs of the quickly evolving cannabis industry, offering customers seamless compliance management solutions and earning government contracts in this rapidly growing market. MOR Analytics, founded in 2019, is an innovative and evolving private company developing a Real World Evidence (“RWE”) and Software as a Service (“SaaS”) analytics platform designed to support the information requirements of constituents across the healthcare industry.

Vireo Health Announces Sale of Assets of Ohio Medical Solutions to Ayr Strategies

Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO, OTCQX: VREOF), the science-focused, multi-state cannabis company with active operations in exclusively medical-only markets and licenses in seven states and the Commonwealth of Puerto Rico, today announced that it has reached a definitive agreement with Ayr Strategies Inc. (CSE:AYR.A)(OTCQX:AYRSF), to sell all of the assets and liabilities of its affiliated company, Ohio Medical Solutions, LLC (“OMS”), for total consideration of $4.85 million.

Kadenwood, LLC, Acquires EcoGen Laboratories

Kadenwood, LLC, a consumer seed-to-shelf CBD company dedicated to fostering trust and transparency in the mainstream wellness category, announced today the acquisition of EcoGen Laboratories, the leading global manufacturer and supplier of hemp-derived CBD materials and formulations. The deal effectively establishes Kadenwood as the largest supplier of vertically-integrated, hemp-derived cannabidiol (CBD) in the US, expanding the company’s ability to scale production of its quality-driven CBD products.

PAOG Announces Acquisition of RespRx

PAO Group, Inc. (OTC Pink: PAOG) has announced the acquisition of RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a treatment for Chronic Obstructive Pulmonary Disease (COPD) under development that is derived from a patented cannabis extraction method. A patent application on the RespRx formulation for symptoms associated with COPD and other similar respiratory conditions has been filed. A trademark on the name RespRx as the brand name for its CBD formulation to treat the symptoms associated with COPD and other similar respiratory conditions has also been filed. The acquisition is part of PAOG’s overall medical cannabis revitalization strategy. Earlier on Tuesday this week, PAOG announced the acquisition of a cannabis cultivation operation developing a proprietary cannabis cultivar from Puration, Inc. (OTC Pink: PURA).